Archives of the Turkish Society of Cardiology
Testosterone replacement therapy and cardiovascular events [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2017; 45(7): 664-672 | DOI: 10.5543/tkda.2017.00531

Testosterone replacement therapy and cardiovascular events

Alp Burak Çatakoğlu1, Muammer Kendirci2
1Department of Cardiology, İstinye University Faculty of Medicine, İstanbul, Turkey
2Department of Urology, İstinye University Faculty of Medicine, İstanbul, Turkey

A low testosterone level and hypogonadism are associated with cardiovascular disease. Aging, chronic health problems, and obesity are all associated with a low testosterone level as well as the presence and severity of cardiovascular disease. Testosterone is increasingly prescribed for patients with clinical hypogonadism and a low testosterone level. The information we have is still contradictory regarding testosterone replacement therapy (TRT) and its association with adverse cardiovascular events. Older patients and patients who are susceptible to cardiovascular diseases could be at risk with a testosterone prescription. This is a review of the literature to discuss the cardiovascular safety of TRT.

Keywords: Cardiovascular events, testosterone; testosterone replacement therapy.

Alp Burak Çatakoğlu, Muammer Kendirci. Testosterone replacement therapy and cardiovascular events. Turk Kardiyol Dern Ars. 2017; 45(7): 664-672

Corresponding Author: Alp Burak Çatakoğlu, Türkiye
© copyright 2017 Archives of the Turkish Society of Cardiology
LookUs & Online Makale